Acute tubular injury and nephrotoxic AKI

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Tubular epithelial cells are vulnerable to oxygen deficit, inflammatory stress and high concentrations of filtered or secreted toxins. Loss of polarity, cell swelling and debris contribute to back-leak and intratubular obstruction, while altered microcirculation sustains the reduction in filtration. ‘Necrosis’ is not required throughout the kidney, so acute tubular injury is the more accurate clinical term. The syndrome is usually inferred from a compatible insult, sediment and course after excluding obstruction and important glomerular or interstitial alternatives.

Nephrotoxic AKI is rarely solved by naming a medicine. Establish whether exposure is essential, whether concentration or dose was excessive for changing renal function, and whether other insults—hypotension, sepsis, contrast, rhabdomyolysis or interacting drugs—lowered reserve. Pharmacy and microbiology input can preserve effective antimicrobial treatment while reducing toxicity through drug-level monitoring, interval adjustment or an alternative agent.

No routine medicine reliably accelerates tubular repair. Care is meticulous and dynamic: secure perfusion without overload, treat the causal illness, prevent further exposure, manage complications and detect the recovery phase. Select antimicrobial, oncology, toxicology and kidney-replacement details from the current specialist protocol for the causal illness and the patient’s physiology.

Key points

Acute tubular injury is the structural syndrome often called acute tubular necrosis; common triggers are prolonged hypoperfusion, sepsis, major surgery, pigment, and dose- or exposure-related nephrotoxins.
The transition from reversible haemodynamic fall in filtration to tubular injury is a continuum, so a patient can have both reduced perfusion and established parenchymal damage.
A creatinine rise typically lags behind the insult. Determine when hypotension, antimicrobial dosing, surgery, contrast, chemotherapy or another exposure occurred rather than dating injury from the blood result.
Urinalysis may be bland; renal tubular epithelial cells and coarse granular ‘muddy brown’ casts support tubular injury when skilled microscopy is available, but their absence does not exclude it.
Aminoglycosides, glycopeptides, amphotericin, cisplatin, antivirals and other agents differ in mechanism and monitoring. Check the exact medicine, route, cumulative exposure, interactions and measured concentrations instead of using a generic nephrotoxin label.
Supportive care means treating sepsis and shock, stopping avoidable insults, adjusting all renally cleared drugs, controlling fluid and electrolytes, ensuring nutrition and initiating replacement therapy for complications—not forcing urine production.
Loop diuretics can relieve fluid overload in a responsive patient but do not reverse tubular injury or improve survival simply by converting oliguria to measured urine.
During recovery, filtration and tubular concentration may recover at different rates. A polyuric phase can produce dehydration, hypokalaemia and hypomagnesaemia even while creatinine is falling.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Ischaemic and septic injury

Prolonged hypoperfusion, shock, severe infection and major surgery expose metabolically active tubular cells to oxygen deficit, inflammatory stress and disordered renal microcirculation.

Medicine and chemical toxicity

Aminoglycosides, glycopeptides, amphotericin, cisplatin, antivirals and other agents can injure tubules through distinct exposure-related mechanisms, amplified by accumulation, interactions or pre-existing impairment.

Pigment and endogenous toxins

Rhabdomyolysis and other pigment-associated insults can contribute to acute tubular injury, particularly alongside hypovolaemia, sepsis or additional nephrotoxic exposure.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Tubular epithelial stress
Oxygen deprivation, inflammation or toxin uptake disrupts epithelial energy production, polarity and membrane integrity, particularly in vulnerable nephron segments.
2
Cell shedding and obstruction
Injured epithelial cells detach into the lumen, where debris and granular casts obstruct flow and increase intratubular pressure.
3
Back-leak and reduced filtration
Damaged tubular barriers allow filtered solute to leak into the interstitium, while altered arteriolar tone and microcirculatory dysfunction sustain a fall in glomerular filtration.
4
Repair and polyuric recovery
Surviving cells proliferate and restore continuity, but filtration may recover before concentrating and electrolyte transport, producing a vulnerable polyuric phase.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Ischaemic tubular injuryRed flag

AKI follows sustained shock, haemorrhage, cardiac arrest, major surgery or prolonged severe depletion and does not promptly resolve after circulation is restored. Multi-organ hypoperfusion and an oliguric trajectory increase suspicion.

Sepsis-associated injuryRed flag

Kidney dysfunction develops during systemic infection through haemodynamic, inflammatory and microvascular mechanisms. Urine output may fall before creatinine rises, and fluid overload can develop despite ongoing circulatory instability.

Dose-related nephrotoxicity

The creatinine increase follows a known toxic exposure, high trough concentration, prolonged course or failure to adjust dosing as filtration deteriorated. Concurrent NSAIDs, contrast or hypotension can amplify susceptibility.

Tubular sediment pattern

Renal tubular epithelial cells and granular casts support ATI, whereas dysmorphic blood with substantial protein suggests a glomerular process and pyuria with systemic hypersensitivity raises interstitial nephritis.

Recovery-phase polyuria

Rising urine volumes after oliguria can represent recovering filtration with persistent concentrating and solute-handling defects. Without replacement tailored to losses, the patient may become depleted and develop sodium, potassium or magnesium disturbance.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Dated creatinine, electrolyte and urine-output trajectoryFirst step
Why
Relate onset and severity to the suspected ischaemic, septic or toxic exposure.
Interpretation and limitations
A continued rise after haemodynamics improve is compatible with established tubular injury, but ongoing obstruction, inflammation or drug exposure must still be excluded. Falling creatinine alongside high output may mark early recovery rather than complete tubular function.
02
Urinalysis and expert urine microscopy
Why
Look for tubular epithelial cells and granular casts while screening for competing intrinsic renal diagnoses.
Interpretation and limitations
Coarse pigmented granular casts make ATI more likely in context, yet sensitivity depends on collection and expertise. Heavy albuminuria, red-cell casts or unexpected sterile pyuria should prompt diagnostic reconsideration.
03
Complete medication administration and exposure record
Why
Identify direct toxins, haemodynamic combinations, dosing errors and cumulative courses that can be changed.
Interpretation and limitations
Compare actual administration times, renal dose recommendations, fluid status and co-exposures with the creatinine curve. A charted prescription is not proof that doses were given or appropriately adjusted.
04
Therapeutic drug concentrations where validated
Why
Guide dosing and toxicity reduction for medicines such as aminoglycosides or glycopeptides under local protocols.
Interpretation and limitations
Interpret the level against exact sampling and dose times; a mistimed sample can mislead. Worsening renal clearance may both result from and increase exposure, requiring pharmacy or microbiology-supported adjustment.
05
Creatine kinase, haemolysis screen and toxin-specific tests
Why
Detect pigment nephropathy, microangiopathy or a toxic exposure when the history or laboratory pattern suggests them.
Interpretation and limitations
Marked CK with haem-positive urine and few red cells supports rhabdomyolysis; anaemia, thrombocytopenia and haemolysis require an urgent TMA pathway; toxicology testing is guided by the suspected agent and time.
06
Renal tract ultrasound
Why
Exclude obstruction when the cause is uncertain, urine output is very low or risk factors are present.
Interpretation and limitations
A non-dilated tract supports but does not prove a parenchymal cause. Very early or retroperitoneal obstruction may be missed, so discrepant clinical suspicion warrants urological or radiological discussion.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Pre-renal haemodynamic AKI

Rapid improvement after correction of a demonstrable perfusion problem supports predominantly haemodynamic injury; persistent dysfunction and granular sediment suggest established tubular damage, although both commonly coexist.

Acute interstitial nephritis

A delayed medicine exposure with sterile pyuria, rash or eosinophilia favours interstitial inflammation, while a clear ischaemic or dose-related toxic insult favours tubular injury.

Glomerulonephritis

Dysmorphic haematuria, red-cell casts, substantial albuminuria, low complement or systemic vasculitic features require an urgent glomerular work-up rather than attribution to tubular injury.

Post-renal obstruction

Anuria, retention symptoms, a palpable bladder or collecting-system dilatation support obstruction; early or encasing disease may lack hydronephrosis, so imaging requires clinical correlation.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Exposure controlStop preventable ongoing tubular insultFirst stepATI is suspected after hypotension, infection, surgery or a potentially nephrotoxic medicine.

11. Build an exposure timeline using observations, operations, cultures, drug administration, levels, contrast and CK rather than relying on the admission diagnosis.
22. Treat shock, infection, pigment release or another primary cause and remove non-essential nephrotoxins immediately; seek an effective substitute when therapy remains essential.
33. Ask pharmacy, microbiology, oncology or toxicology to adjust dose, interval and monitoring for the exact agent and rapidly changing clearance.
44. Record the suspected causal association and prevention plan, but avoid an inaccurate permanent allergy label for a dose-related toxic effect.

02SupportManage established tubular injuryCreatinine or oliguria persists after initial haemodynamic correction and ATI is the leading diagnosis.

11. Set an individual fluid goal from perfusion, losses, congestion and daily weight; neither maintenance fluid nor blanket restriction is universally correct.
22. Adjust every renally cleared medicine, avoid potassium and sodium loads where hazardous, maintain appropriate nutrition and provide thrombosis prophylaxis adapted to renal function.
33. Treat hyperkalaemia, acidosis, pulmonary oedema and uraemic manifestations promptly, and involve nephrology before emergency replacement therapy becomes unavoidable.
44. Do not use dopamine or diuretics to ‘kick-start’ the kidney; reserve loop diuretic for clinically important fluid overload with monitoring of response.

03RecoveryNavigate the diuretic phaseUrine output rises substantially after an oliguric or severe ATI episode.

11. Quantify hourly or interval urine losses, oral intake, weight and postural status, and distinguish appropriate mobilisation of oedema from excessive depletion.
22. Check sodium, potassium, magnesium, phosphate and creatinine more frequently while losses are high, replacing fluid and electrolytes according to results.
33. Recalculate drug exposure as clearance improves so that temporary renal reductions do not become subtherapeutic, particularly for antimicrobials.
44. Arrange post-AKI follow-up and document the causative exposure, peak stage, recovery and advice about future use of the implicated medicine.

Key medicines and prescribing safety2 treatments · regimens, roles and cautions

Relieves pulmonary or systemic congestion in a patient who can respond; it does not repair tubules or shorten ATI by itself.

Loop diuretic for fluid overload

Use an intravenous or oral dose selected from prior diuretic exposure, renal function and the local acute heart-failure or renal protocol, then assess urine and sodium response promptly.

Avoid prescribing solely to convert oliguria into urine. Monitor pressure, sodium, potassium, magnesium, hearing risk at high exposure and cumulative balance; escalating ineffective doses must not delay renal replacement assessment.

Provides effective antimicrobial therapy for selected severe infections while structured monitoring limits cumulative renal and ototoxic exposure.

Aminoglycoside under level-guided prescribing

When clinically indispensable, use the locally approved weight- and indication-based regimen with exact timed concentrations and extend or withhold subsequent dosing as renal clearance changes.

Do not invent a dose from eGFR during unstable AKI. Involve microbiology and pharmacy, verify actual sampling time, avoid concurrent nephrotoxins where possible and change therapy if toxicity outweighs microbiological benefit.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Severe kidney failure

Extensive tubular dysfunction can cause persistent oliguria, rising nitrogenous waste and a temporary need for kidney replacement therapy while epithelial recovery evolves.

Fluid and electrolyte instability

Oliguric injury promotes pulmonary oedema, hyperkalaemia and acidosis, whereas recovering tubules may waste water, potassium and magnesium despite a falling creatinine.

Medicine accumulation

Rapidly changing filtration can increase exposure to renally cleared antimicrobials, sedatives and other medicines, adding neurological, cardiac or further renal toxicity.

Chronic kidney impairment

Incomplete repair, severe initial injury or repeated episodes can leave nephron loss, interstitial fibrosis and increased risk of later chronic kidney disease.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Plot creatinine and urine output against the exact times of shock, surgery, antimicrobial doses, drug levels and interventions so that cause and response remain visible.
Check potassium, bicarbonate, sodium, magnesium and phosphate frequently enough to catch both oliguric accumulation and polyuric depletion.
Follow daily weight, oxygen need, lung findings and cumulative fluid because ATI patients readily move from resuscitation to harmful overload.
For concentration-guided medicines, document dose time, sample time, result, dosing decision and owner; a level without timing is unsafe data.
During recovery, review all renal dose reductions and withheld medicines repeatedly because improving clearance can change efficacy and toxicity within days.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Creatinine dates recognition, not injury

Because creatinine accumulates after filtration falls, the causal hypotensive or toxic event may precede the diagnostic result by many hours. Exposure chronology is essential for attribution and prevention.

Oliguria is not required

Many toxic and septic tubular injuries remain non-oliguric. Preserved volume can reduce immediate fluid complications but does not guarantee mild damage or safe medicine clearance.

A level needs a timestamp

Aminoglycoside and glycopeptide concentrations are interpretable only in relation to administration and sampling. Incorrect timing can produce both unnecessary withholding and dangerous repeat dosing.

Polyuria can be incomplete recovery

Glomerular filtration may improve before tubular concentrating and electrolyte transport recover. High output therefore demands closer replacement and biochemical monitoring, not immediate discharge.

Toxicity is often multifactorial

A correctly prescribed medicine can become harmful after shock or reduced clearance, and several modest exposures may combine. Attribution should recognise contributory factors rather than falsely isolating one culprit.

11Common pitfallsFrequent interpretation and management errors.

01
Calling persistent AKI ‘still pre-renal’ after circulation is restored can delay recognition of established tubular injury and its complications.
02
Assuming a medicine is safely dosed because the electronic prescription was correct yesterday ignores rapidly falling clearance and actual administration times.
03
Treating urine volume produced by a loop diuretic as evidence of tubular recovery confuses symptom control with restoration of filtration.
04
Replacing all polyuric output litre-for-litre without assessing weight, congestion and electrolytes may perpetuate unnecessary diuresis or overload.
05
Using a permanent immune-allergy label for predictable dose-related nephrotoxicity can unnecessarily remove future therapeutic options; document the reaction precisely.